Hypopituitarism MRI: Difference between revisions

Jump to navigation Jump to search
Line 7: Line 7:


==MRI==
==MRI==
*[[Magnetic resonance imaging|MRI]] scan with intravenous gadolinium is the imaging procedure of choice in diagnosis of [[hypopituitarism]] . It is preferred over the [[CT scan]] as [[optic chiasm]], [[pituitary stalk]], and [[cavernous sinuses]] can be seen in [[Magnetic resonance imaging|MRI]].<ref name="Vance1994">{{cite journal|last1=Vance|first1=Mary Lee|title=Hypopituitarism|journal=New England Journal of Medicine|volume=330|issue=23|year=1994|pages=1651–1662|issn=0028-4793|doi=10.1056/NEJM199406093302306}}</ref>  
*[[Magnetic resonance imaging|MRI]] scan with intravenous gadolinium is the imaging procedure of choice in the [[diagnosis]] of [[hypopituitarism|hypopituitarism.]] It is preferred over the [[CT scan]] as [[optic chiasm]], [[pituitary stalk]], and [[cavernous sinuses]] can be seen in [[Magnetic resonance imaging|MRI]].<ref name="Vance1994">{{cite journal|last1=Vance|first1=Mary Lee|title=Hypopituitarism|journal=New England Journal of Medicine|volume=330|issue=23|year=1994|pages=1651–1662|issn=0028-4793|doi=10.1056/NEJM199406093302306}}</ref>  
*[[Magnetic resonance imaging|MRI]] is the single best imaging modality in the evaluation of [[Sella|sellar]] masses as certain findings are suggestive of some specific sellar masses and help to differentiate them
*[[Magnetic resonance imaging|MRI]] is the single best [[imaging]] [[modality]] in the evaluation of [[Sella|sellar]] masses as certain findings are suggestive of some specific sellar masses and help to [[differentiate]] them
*If MRI is not possible due to any reason, high-resolution CT scan with contrast administration, in coronal plane, may be used as an alternative
*If [[MRI]] is not possible due to any reason, high-resolution [[CT scan]] with [[contrast]] administration, in [[coronal plane]], may be used as an alternative
*An [[magnetic resonance imaging]] ([[Magnetic resonance imaging|MRI]]) scan may show a three-dimensional image of [[pituitary gland]], [[hypothalamus]], and the [[organs]] near them.
*An [[magnetic resonance imaging]] ([[Magnetic resonance imaging|MRI]]) scan may show a three-dimensional [[image]] of [[pituitary gland]], [[hypothalamus]], and the [[organs]] near them.
*[[Magnetic resonance imaging|MRI]] is used to detect the underlying cause of like the [[pituitary adenoma]] that can be seen as a mass with [[hormonal]] hypersecretion.
*[[Magnetic resonance imaging|MRI]] is used to detect the underlying cause of like the [[pituitary adenoma]] that can be seen as a mass with [[hormonal]] hypersecretion.
*There is a positive [[correlation]] between [[Magnetic resonance imaging|MRI]] <nowiki/>findings and the number of [[Pituitary hormone|pituitary hormonal]] deficiencies.<ref name="pmid20197674">{{cite journal |vauthors=Li G, Shao P, Sun X, Wang Q, Zhang L |title=Magnetic resonance imaging and pituitary function in children with panhypopituitarism |journal=Horm Res Paediatr |volume=73 |issue=3 |pages=205–9 |year=2010 |pmid=20197674 |doi=10.1159/000284363 |url=}}</ref><ref name="pmid21646285">{{cite journal |vauthors=Child CJ, Zimmermann AG, Woodmansee WW, Green DM, Li JJ, Jung H, Erfurth EM, Robison LL |title=Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study |journal=Eur. J. Endocrinol. |volume=165 |issue=2 |pages=217–23 |year=2011 |pmid=21646285 |pmc=3132593 |doi=10.1530/EJE-11-0286 |url=}}</ref>
*There is a positive [[correlation]] between [[Magnetic resonance imaging|MRI]] <nowiki/>findings and the number of [[Pituitary hormone|pituitary hormonal]] deficiencies.<ref name="pmid20197674">{{cite journal |vauthors=Li G, Shao P, Sun X, Wang Q, Zhang L |title=Magnetic resonance imaging and pituitary function in children with panhypopituitarism |journal=Horm Res Paediatr |volume=73 |issue=3 |pages=205–9 |year=2010 |pmid=20197674 |doi=10.1159/000284363 |url=}}</ref><ref name="pmid21646285">{{cite journal |vauthors=Child CJ, Zimmermann AG, Woodmansee WW, Green DM, Li JJ, Jung H, Erfurth EM, Robison LL |title=Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study |journal=Eur. J. Endocrinol. |volume=165 |issue=2 |pages=217–23 |year=2011 |pmid=21646285 |pmc=3132593 |doi=10.1530/EJE-11-0286 |url=}}</ref>
*An [[MRI]] lesion needs to be related to clinical and lab findings. The absence of an [[Magnetic resonance imaging|MRI]] lesion mostly indicates a non-organic etiology.  
*An [[MRI]] lesion needs to be related to clinical and lab findings. The absence of an [[Magnetic resonance imaging|MRI]] lesion mostly indicates a non-organic etiology.  

Revision as of 20:56, 29 September 2017

Hypopituitarism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypopituitarism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypopituitarism MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypopituitarism MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypopituitarism MRI

CDC on Hypopituitarism MRI

Hypopituitarism MRI in the news

Blogs on Hypopituitarism MRI

Directions to Hospitals Treating Hypopituitarism

Risk calculators and risk factors for Hypopituitarism MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2] Iqra Qamar M.D.[3]

Overview

MRI is the imaging procedure of choice in the diagnosis of hypopituitarism. It is preferred over the CT scan as optic chiasm, pituitary stalk, and cavernous sinuses can be seen in MRI. An MRI lesion needs to be related to clinical and lab findings. The absence of an MRI lesion mostly indicates a non-organic etiology. Cystic lesions, such as Rathke's cleft cysts may have a low-intensity signal on T1-weighted images and a high-intensity signal on T2-weighted images. Meningiomas have a homogenous postcontrast enhancement than pituitary adenomas and have a suprasellar attachment. Hemorrhage into the pituitary gland results in a high-intensity signal on both T1- and T2-weighted images.

MRI

  • Cystic lesions, such as Rathke's cleft cysts may have
    • a low-intensity signal on T1-weighted images
    • a high-intensity signal on T2-weighted images
Empty Sella. Source: Wikimedia Commons[8]


MRI showing necrotic pituitary adenoma (Source: Case courtesy of A.Prof Frank Gaillard, Radiopaedia.org, rID: 17664)

Patient #1: Pituitary macroadenoma

Gallery

References

  1. Vance, Mary Lee (1994). "Hypopituitarism". New England Journal of Medicine. 330 (23): 1651–1662. doi:10.1056/NEJM199406093302306. ISSN 0028-4793.
  2. Li G, Shao P, Sun X, Wang Q, Zhang L (2010). "Magnetic resonance imaging and pituitary function in children with panhypopituitarism". Horm Res Paediatr. 73 (3): 205–9. doi:10.1159/000284363. PMID 20197674.
  3. Child CJ, Zimmermann AG, Woodmansee WW, Green DM, Li JJ, Jung H, Erfurth EM, Robison LL (2011). "Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study". Eur. J. Endocrinol. 165 (2): 217–23. doi:10.1530/EJE-11-0286. PMC 3132593. PMID 21646285.
  4. Pozzi Mucelli, R. S.; Frezza, F.; Magnaldi, S.; Proto, G. (1992). "Magnetic resonance imaging in patients with panhypopituitarism". European Radiology. 2 (1): 42–46. doi:10.1007/BF00714180. ISSN 0938-7994.
  5. Imashuku S, Kudo N, Kaneda S, Kuroda H, Shiwa T, Hiraiwa T, Inagaki A, Morimoto A (2011). "Treatment of patients with hypothalamic-pituitary lesions as adult-onset Langerhans cell histiocytosis". Int. J. Hematol. 94 (6): 556–60. doi:10.1007/s12185-011-0955-z. PMID 22015494.
  6. De Herder WW, Lamberts SW (1995). "Imaging of pituitary tumours". Baillieres Clin. Endocrinol. Metab. 9 (2): 367–89. PMID 7625990.
  7. Taylor SL, Barakos JA, Harsh GR, Wilson CB (1992). "Magnetic resonance imaging of tuberculum sellae meningiomas: preventing preoperative misdiagnosis as pituitary macroadenoma". Neurosurgery. 31 (4): 621–7, discussion 627. PMID 1407446.
  8. "File:Empty Sella MRT FLAIR sag 001.jpg - Wikimedia Commons". Text "Hellerhoff " ignored (help)
  9. 9.0 9.1 Case contributed by Radswiki Radiopaedia(original file ‘’here’’).Creative Commons BY-SA-NC


Template:WH Template:WS